LEVOTHYROXINE SODIUM tablet United States - English - NLM (National Library of Medicine)

levothyroxine sodium tablet

tya pharmaceuticals - levothyroxine sodium (unii: 9j765s329g) (levothyroxine - unii:q51bo43mg4) - levothyroxine sodium anhydrous 50 ug - levothyroxine sodium is used for the following indications: – as replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis.  specific indications include: primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism. primary hypothyroidism may result from functional deficiency, primary atrophy, partial or total congenital absence of the thyroid gland, or from the effects of surgery, radiation, or drugs, with or without the presence of goiter. hypothyroidism – in the treatment or prevention of various types of euthyroid goiters (see and  ), including thyroid nodules (see and  ), subacute or chronic lymphocytic thyroiditis (hashimoto’s thyroiditis), multinodular goiter (see  and  ) and, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.

LEVOTHYROXINE SODIUM tablet United States - English - NLM (National Library of Medicine)

levothyroxine sodium tablet

stat rx usa llc - levothyroxine sodium (unii: 9j765s329g) (levothyroxine - unii:q51bo43mg4) - levothyroxine sodium 0.05 mg - levothyroxine sodium is used for the following indications: hypothyroidism - as replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. specific indications include: primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism. primary hypothyroidism may result from functional deficiency, primary atrophy, partial or total congenital absence of the thyroid gland, or from the effects of surgery, radiation, or drugs, with or without the presence of goiter. pituitary tsh suppression - in the treatment or prevention of various types of euthyroid goiters (see warnings and precautions ), including thyroid nodules (see warnings and precautions ), subacute or chronic iymphocytic thyroiditis (hashimoto's thyroiditis), multinodular goiter (see warnings and precautions ), and, as an adjunct to surgery and radioiodine therapy in the managem

LEVOTHYROXINE tablet United States - English - NLM (National Library of Medicine)

levothyroxine tablet

northwind pharmaceuticals, llc - levothyroxine sodium (unii: 9j765s329g) (levothyroxine - unii:q51bo43mg4) - levothyroxine sodium anhydrous 25 ug - levothyroxine sodium is used for the following indications: hypothyroidism – as replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. specific indications include: primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism. primary hypothyroidism may result from functional deficiency, primary atrophy, partial or total congenital absence of the thyroid gland, or from the effects of surgery, radiation, or drugs, with or without the presence of goiter. pituitary tsh suppression – in the treatment or prevention of various types of euthyroid goiters (see warnings and precautions), including thyroid nodules (see warnings and precautions), subacute or chronic lymphocytic thyroiditis (hashimoto’s thyroiditis), multinodular goiter (see warnings and precautions) and, as an adjunct to surgery and radioiodine therapy in the management of thyr

LEVOTHYROXINE SODIUM tablet United States - English - NLM (National Library of Medicine)

levothyroxine sodium tablet

northwind pharmaceuticals, llc - levothyroxine sodium (unii: 9j765s329g) (levothyroxine - unii:q51bo43mg4) - levothyroxine sodium anhydrous 0.137 mg - levothyroxine sodium is used for the following indications: hypothyroidism – as replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. specific indications include: primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism. primary hypothyroidism may result from functional deficiency, primary atrophy, partial or total congenital absence of the thyroid gland, or from the effects of surgery, radiation, or drugs, with or without the presence of goiter. pituitary tsh suppression – in the treatment or prevention of various types of euthyroid goiters (see warnings and precautions), including thyroid nodules (see warnings and precautions), subacute or chronic lymphocytic thyroiditis (hashimoto’s thyroiditis), multinodular goiter (see warnings and precautions) and, as an adjunct to surgery and radioiodine therapy in the management of thyr

LEVOTHYROXINE SODIUM tablet United States - English - NLM (National Library of Medicine)

levothyroxine sodium tablet

northwind pharmaceuticals - levothyroxine sodium (unii: 9j765s329g) (levothyroxine - unii:q51bo43mg4) - levothyroxine sodium anhydrous 0.1 mg - levothyroxine sodium is used for the following indications: hypothyroidism – as replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. specific indications include: primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism. primary hypothyroidism may result from functional deficiency, primary atrophy, partial or total congenital absence of the thyroid gland, or from the effects of surgery, radiation, or drugs, with or without the presence of goiter. pituitary tsh suppression – in the treatment or prevention of various types of euthyroid goiters (see warnings and precautions), including thyroid nodules (see warnings and precautions), subacute or chronic lymphocytic thyroiditis (hashimoto’s thyroiditis), multinodular goiter (see warnings and precautions) and, as an adjunct to surgery and radioiodine therapy in the management of thyr

Levothyroxine 100 micrograms/5 ml Oral Solution Ireland - English - HPRA (Health Products Regulatory Authority)

levothyroxine 100 micrograms/5 ml oral solution

jensonr+ (ireland) limited - levothyroxine sodium - oral solution - 100 micrograms/5ml - thyroid hormones; levothyroxine sodium

Levothyroxine 25 micrograms/5 ml Oral Solution Ireland - English - HPRA (Health Products Regulatory Authority)

levothyroxine 25 micrograms/5 ml oral solution

jensonr+ (ireland) limited - levothyroxine sodium - oral solution - 25 micrograms/5ml - thyroid hormones; levothyroxine sodium

Levothyroxine 50 micrograms/5 ml Oral Solution Ireland - English - HPRA (Health Products Regulatory Authority)

levothyroxine 50 micrograms/5 ml oral solution

jensonr+ (ireland) limited - levothyroxine sodium - oral solution - 50 micrograms/5ml - thyroid hormones; levothyroxine sodium

Levothyroxine 100 micrograms per 5 ml oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

levothyroxine 100 micrograms per 5 ml oral solution

amdipharm limited - levothyroxine sodium - oral solution - 100 micrograms/5ml - thyroid hormones; levothyroxine sodium

Levothyroxine 50 micrograms per 5 ml oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

levothyroxine 50 micrograms per 5 ml oral solution

amdipharm limited - levothyroxine sodium - oral solution - 50 micrograms/5ml - thyroid hormones; levothyroxine sodium